169,00 € – 276,00 €
This antibody reacts with the CD9-antigen, which is expressed on the surface of developing B lymphocytes, platelets, monocytes, eosinophils, basophils, stimulated T lymphocytes and by neurons and glial cells in the peripheral nervous system. In pre-B cells and platelets, CD9 antigen regulates cell activation and aggregation possibly through an association with the integrin CD41/CD61 (GPIIb/GPIIIa).
Conjugated | |
---|---|
Size | |
Clone | |
Gene ID | |
Format | |
Species Reactivity | |
Isotype | |
Tested Applications | |
Clonality | |
Regulatory Status | |
UniProt | |
Mw | |
Storage | Store in the dark at 2-8°C. |
Other names | DRAP-27, MRP-1, p24, CD9 antigen, 5H9 antigen, Cell growth-inhibiting gene 2 protein, Leukocyte antigen MIC3, Motility-related protein, MRP-1, Tetraspanin-29, Tspan-29. |
Buffer | The reagent is provided in aqueous buffered solution containing protein stabilizer, and ≤0.09% sodium Azide (NaN3). |
Immunogen | Tissue / cell preparation (Human): Pre B cell line NALM-6. |
Concentration | Please refer to the Certificate of Analysis for the lot-specific concentration. Typically 0,05 mg/ml. |
CD9, clone VJ1/20, is a mAb intended for the identification/ enumeration of human platelets using FCM. This reagent is effective for direct IF staining of human tissue for FCM analysis using ≤1 μg/10^6 cells.
Technical Data Sheet (TDS) (CE-IVD) – (English)
Hoja Técnica (TDS) (CE-IVD) – (Español)
Technical Data Sheet (TDS) (RUO) – (English)
Safety Sheet (MSDS) (CE-IVD) – (English)
Safety Sheet (MSDS) (RUO) – (English)
Safety Sheet (Purified) (MSDS) (RUO) – (English)
Instruction for Use (IFU) (CE-IVD) – (German)
Instruction for Use (IFU) (CE-IVD) – (Italian)
Product description | Reference | Title | Authors | Journal | Year | |
---|---|---|---|---|---|---|
Product description | Reference | Title | Authors | Journal | Year |
© 2023 Immunostep